Conducted

November 19, 2021

4776 US adults surveyed

Share

Should pharmaceutical companies be required to license COVID‑19 treatments to generic drug makers?

Conducted November 19, 2021

YouGov surveyed 4776 US adults

42%
19%
39%
Should pharmaceutical companies be required to license COVID‑19 treatments to generic drug makers?

Conducted November 19, 2021

YouGov surveyed 4776 US adults

By:
42%
19%
39%